Literature DB >> 15906350

Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?

Lei P Wong, Kristi T W Lai, Elaine Tsui, Kwok H Kwong, Raymond H N Tsang, Edmond S K Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15906350     DOI： 10.1002/ijc.21194

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  3 in total

Review 1.  The other side of the coin: Leveraging Epstein-Barr virus in research and therapy.

Authors:  Fenggang Yu; Wei Jian Tan; Yanan Lu; Paul A MacAry; Kwok Seng Loh
Journal:  Oral Oncol       Date:  2016-07-21       Impact factor: 5.337

2.  Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma.

Authors:  Guo-Ying Liu; Wei-Xiong Xia; Zhuo-Fei Bi; Nian Lu; Wang-Zhong Li; Wei-Xin Bei; Hu Liang; Jun-Zhi Xie; Yi-Min Liu; He-Rui Yao; Yan-Qun Xiang
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

3.  Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.

Authors:  John Malcolm Nicholls; Victor Ho-Fun Lee; Sik-Kwan Chan; Ka-Chun Tsang; Cheuk-Wai Choi; Dora Lai-Wan Kwong; Ka-On Lam; Sum-Yin Chan; Chi-Chung Tong; Tsz-Him So; To-Wai Leung; Mai-Yee Luk; Pek-Lan Khong; Anne Wing-Mui Lee
Journal:  Br J Cancer       Date:  2019-09-17       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.